Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Heron Therapeutics, Inc. (HRTX)

« Back to company index

HRTX Chatter Timeline

Stock Ticker for HRTX

Most Active Tweeters for HRTX

UserTweets
@Tickeron 10
@FlashAlert_me 7
@HealthcareBeat 6
@InsiderAlerts4U 5
@stocknewstimes 3

Recent Tweets for HRTX

Tickeron @Tickeron
$HRTX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/unPKGcn208
October 27th 2020, 6:10pm
Tickeron @Tickeron
$HRTX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/b1QwXx4S8S
October 26th 2020, 5:10pm
PMDiChristina @PMDiChristina
Been watching this name for a while, like how it’s looking. Showing some life $HRTX #chartIdea #StockIdea https://t.co/uTBijvp5t6
October 25th 2020, 7:10pm
Tickeron @Tickeron
$HRTX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/HN0oPWsfD8
October 25th 2020, 6:10pm
Tickeron @Tickeron
$HRTX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/7gWoAhHUEs
October 24th 2020, 6:10pm
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in HERON THERAPEUTICS INC. COMMO $HRTX https://t.co/bRbiuAgXJV
October 24th 2020, 3:10pm
bbnsnews @bbnsnews
Heron Therapeutics $HRTX Stock Price Up 6.1% https://t.co/0097LeqR5m
October 24th 2020, 10:10am
Tickeron @Tickeron
$HRTX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/w3r3Bl7TRz
October 23rd 2020, 8:10pm
MarginCall3 @MarginCall3
Just when you think might be a break out Heron $HRTX retreats It has a drug that was rejected by FDA over some adm… https://t.co/5y6yxs54OY
October 23rd 2020, 3:10pm
bkfViking123 @bkfViking123
$hrtx 200 day resistance .. watch list https://t.co/KbpYqTpLG3
October 22nd 2020, 4:10pm
TranscriptDaily @TranscriptDaily
Heron Therapeutics, Inc. $HRTX Expected to Post Q3 2020 Earnings of -$0.56 Per Share https://t.co/9pLzLdexRt
October 22nd 2020, 8:10am
stocknewstimes @stocknewstimes
Heron Therapeutics, Inc. $HRTX Expected to Post Q3 2020 Earnings of -$0.56 Per Share https://t.co/KpKewobi4e
October 22nd 2020, 8:10am
Tickeron @Tickeron
$HRTX in Downtrend: its price may drop because broke its higher Bollinger Band on October 8, 2020. View odds for th… https://t.co/wfWXlwv65Q
October 21st 2020, 8:10pm
WeekHerald @WeekHerald
Heron Therapeutics, Inc. $HRTX Receives Average Recommendation of “Buy” from Analysts https://t.co/PAa4yWLvWQ
October 21st 2020, 4:10pm
OlympiaReport @OlympiaReport
Analysts Set Heron Therapeutics, Inc. $HRTX Price Target at $33.83 https://t.co/XyQ6crBNLY
October 21st 2020, 4:10pm
ChartMill @ChartMill
Although the technical rating is bad, $HRTX does present a nice setup opportunity. https://t.co/SIxKnovLHh https://t.co/Xu2bsDGFb8
October 21st 2020, 4:10am
ThisLincolnian @ThisLincolnian
Kezar Life Sciences $KZR versus Heron Therapeutics $HRTX Head-To-Head Comparison https://t.co/vTWsJx7gpM
October 21st 2020, 4:10am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in HERON THERAPEUTICS INC. COMMO $HRTX https://t.co/YHKLP8b3AH
October 20th 2020, 10:10pm
usptoTM @usptoTM
DALA application for trademark filed by Heron Therapeutics, Inc. https://t.co/I09tggYTkO #DALA $HRTX $APPA https://t.co/rBLv93f8jo
October 20th 2020, 8:10pm
Tickeron @Tickeron
$HRTX in Downtrend: its price may drop because broke its higher Bollinger Band on October 8, 2020. View odds for th… https://t.co/BIQfeAdi3Y
October 20th 2020, 6:10pm
HealthcareBeat @HealthcareBeat
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $HRTX https://t.co/Dw2NnIxR2f
October 20th 2020, 5:10pm
YuMiStockTrade @YuMiStockTrade
https://t.co/v6MD2eZBM5 $HRTX Moving
October 19th 2020, 6:10pm
GiancarloChimie @GiancarloChimie
RT @RamsCharts: $HRTX is consolidating but it could break out either way. https://t.co/GDKjXGU6kP
October 19th 2020, 4:10pm
RamsCharts @RamsCharts
$HRTX is consolidating but it could break out either way. https://t.co/KadH5PI2Xc https://t.co/GDKjXGU6kP
October 19th 2020, 4:10pm
tradersreport @tradersreport
RT @Tickeron: $HRTX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on October 8, 2020. View odds for this…
October 18th 2020, 6:10pm
Tickeron @Tickeron
$HRTX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on October 8, 2020. View odds… https://t.co/muYCOZ6CKW
October 18th 2020, 6:10pm
dailypoliticaln @dailypoliticaln
Kezar Life Sciences $KZR & Heron Therapeutics $HRTX Financial Contrast https://t.co/9l53ptXKYg
October 18th 2020, 1:10am
WatchlistN @WatchlistN
Reviewing Kezar Life Sciences $KZR and Heron Therapeutics $HRTX https://t.co/im1S3eNWL4
October 18th 2020, 1:10am
AmericanBanking @AmericanBanking
Reviewing Kezar Life Sciences $KZR and Heron Therapeutics $HRTX https://t.co/gTLsyrF7Yv #stocks
October 18th 2020, 1:10am
Tickeron @Tickeron
$HRTX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on October 8, 2020. View odds… https://t.co/NmVeYk9Swq
October 17th 2020, 7:10pm
Tickeron @Tickeron
$HRTX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on October 8, 2020. View odds… https://t.co/YsHD6iEhlC
October 16th 2020, 7:10pm
EnterpriseLeade @EnterpriseLeade
Analysts Set Heron Therapeutics, Inc. $HRTX Price Target at $33.83 https://t.co/HofAIp7ezu
October 16th 2020, 11:10am
stocknewstimes @stocknewstimes
Brokerages Set Heron Therapeutics, Inc. $HRTX Target Price at $33.83 https://t.co/D8DYnin4h1
October 16th 2020, 11:10am
stocknewstimes @stocknewstimes
Heron Therapeutics, Inc. $HRTX Given Average Rating of “Buy” by Brokerages https://t.co/D7XrsCs2GN
October 16th 2020, 11:10am
AmericanBanking @AmericanBanking
Heron Therapeutics, Inc. $HRTX Given Average Rating of “Buy” by Brokerages https://t.co/11FpVocGdQ #stocks
October 16th 2020, 11:10am
EnterpriseLeade @EnterpriseLeade
Heron Therapeutics, Inc. $HRTX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/SWWrMo70tO
October 16th 2020, 10:10am
HealthcareBeat @HealthcareBeat
765 shares acquired by Davis Stephen (Director), reported in a new form 4 filed with the SEC $HRTX https://t.co/QYRkW2exZF
October 15th 2020, 10:10pm
HealthcareBeat @HealthcareBeat
Poyhonen John (President & CCO) acquired new securities, reported in a new form 4 filed with the SEC $HRTX https://t.co/CoUK3P74ay
October 15th 2020, 9:10pm
HealthcareBeat @HealthcareBeat
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $HRTX https://t.co/GmciL7YNSR
October 15th 2020, 9:10pm
InsiderAlerts4U @InsiderAlerts4U
$HRTX: New Insider Filing on HERON THERAPEUTICS, INC. /DE/'s President & CCO JOHN POYHONEN: https://t.co/MyASZMTfdM
October 15th 2020, 5:10pm
InsiderAlerts4U @InsiderAlerts4U
$HRTX: New Insider Filing on HERON THERAPEUTICS, INC. /DE/'s VP, Chief Accounting Officer LISA PERAZA: https://t.co/nJY3ukIrwF
October 15th 2020, 4:10pm
InsiderAlerts4U @InsiderAlerts4U
$HRTX: New Insider Filing on HERON THERAPEUTICS, INC. /DE/'s Chief Executive Officer BARRY D QUART: https://t.co/r7YoITyqTh
October 15th 2020, 4:10pm
InsiderAlerts4U @InsiderAlerts4U
$HRTX: New Insider Filing on HERON THERAPEUTICS, INC. /DE/'s Director STEPHEN DAVIS: https://t.co/1i2ks9pknq
October 15th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$HRTX [15s. delayed] filed SEC form 4: VP, Chief Accounting Officer Peraza Lisa: Transacted Derivative Securities… https://t.co/Lzb2moN0V9
October 15th 2020, 4:10pm
InsiderAlerts4U @InsiderAlerts4U
$HRTX: New Insider Filing on HERON THERAPEUTICS, INC. /DE/'s Director WAAGE CHRISTIAN: https://t.co/FVObudl9HT
October 15th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$HRTX [15s. delayed] filed SEC form 3: VP, Chief Accounting Officer Peraza Lisa: https://t.co/wIWPGfOOm1
October 15th 2020, 4:10pm
HealthcareBeat @HealthcareBeat
Manhard Kimberly (EVP, Drug Development) acquired new securities, reported in a new form 4 filed with the SEC $HRTX https://t.co/9wms0KhCLo
October 15th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$HRTX [15s. delayed] filed SEC form 4: EVP, Drug Development MANHARD KIMBERLY: Transacted Derivative Securities be… https://t.co/OtWvA57ft5
October 15th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$HRTX [15s. delayed] filed SEC form 4: President & CCO POYHONEN JOHN: Transacted Derivative Securities between 202… https://t.co/vEOppUPsSQ
October 15th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$HRTX [15s. delayed] filed SEC form 4: Chief Executive Officer Quart Barry D: Acquired 1,158 of Common Stock at pr… https://t.co/1ttVaDm2Nj
October 15th 2020, 4:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.